These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9850063)

  • 1. Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma.
    Reichert TE; Day R; Wagner EM; Whiteside TL
    Cancer Res; 1998 Dec; 58(23):5344-7. PubMed ID: 9850063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma.
    Reichert TE; Scheuer C; Day R; Wagner W; Whiteside TL
    Cancer; 2001 Jun; 91(11):2136-47. PubMed ID: 11391595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
    Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
    Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The expression of zeta-chain of the T cell receptor as prognostic marker for patients with head and neck cancer].
    Müller D; Lang S; Roskrow M; Wollenberg B
    Laryngorhinootologie; 2002 Jul; 81(7):516-20. PubMed ID: 12173063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma.
    Dworacki G; Meidenbauer N; Kuss I; Hoffmann TK; Gooding W; Lotze M; Whiteside TL
    Clin Cancer Res; 2001 Mar; 7(3 Suppl):947s-957s. PubMed ID: 11300496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
    Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
    Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
    Tomsová M; Melichar B; Sedláková I; Steiner I
    Gynecol Oncol; 2008 Feb; 108(2):415-20. PubMed ID: 18037158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
    Zhong LP; Li J; Zhang CP; Zhu HG; Sun J; Zhang ZY
    Arch Oral Biol; 2007 Aug; 52(8):740-7. PubMed ID: 17331461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma.
    Nemes JA; Nemes Z; Márton IJ
    J Oral Pathol Med; 2005 May; 34(5):274-9. PubMed ID: 15817070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis.
    Kato H; Nakajima M; Masuda N; Faried A; Sohda M; Fukai Y; Miyazaki T; Fukuchi M; Tsukada K; Kuwano H
    J Surg Oncol; 2005 May; 90(2):89-94. PubMed ID: 15844180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients.
    Ogino T; Bandoh N; Hayashi T; Miyokawa N; Harabuchi Y; Ferrone S
    Clin Cancer Res; 2003 Sep; 9(11):4043-51. PubMed ID: 14519625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of monocytes/macrophages in TCR-zeta chain downregulation and apoptosis of T lymphocytes in malignant pleural effusions.
    Sikora J; Dworacki G; Giersz R; Zeromski J
    J Biol Regul Homeost Agents; 2004; 18(1):26-32. PubMed ID: 15323357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib up-regulates the expression of the zeta chain of T cell receptor complex in tumor-infiltrating lymphocytes in human cervical cancer.
    Ferrandina G; Ranelletti FO; Legge F; Salutari V; Martinelli E; Fattorossi A; Lorusso D; Zannoni G; Vellone V; Paglia A; Scambia G
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2055-60. PubMed ID: 16609015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathologic features and prognostic factors of cervical lymph node metastasis in oral squamous cell carcinoma].
    Li XM; DI B; Shang YD; Li J; Cheng JM
    Ai Zheng; 2005 Feb; 24(2):208-12. PubMed ID: 15694035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scatter factor receptor (c-Met) as possible prognostic factor in patients with oral squamous cell carcinoma.
    Lo Muzio L; Leonardi R; Mignogna MD; Pannone G; Rubini C; Pieramici T; Trevisiol L; Ferrari F; Serpico R; Testa N; De Rosa G; Staibano S
    Anticancer Res; 2004; 24(2C):1063-9. PubMed ID: 15154624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absent or low expression of T-cell receptor zeta-chain in T cells infiltrating human pathological skin conditions.
    Alaibac M; Pigozzi B; Saponeri A; Belloni-Fortina A; Peserico A
    Arch Dermatol Res; 2002 Nov; 294(8):380-2. PubMed ID: 12420108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced gamma-catenin expression and poor survival in oral squamous cell carcinoma.
    Närkiö-Mäkelä M; Pukkila M; Lagerstedt E; Virtaniemi J; Pirinen R; Johansson R; Kosunen A; Lappalainen K; Hämäläinen K; Kosma VM
    Arch Otolaryngol Head Neck Surg; 2009 Oct; 135(10):1035-40. PubMed ID: 19841345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiopoietin-1 and -2 expression in recurrent squamous cell carcinoma of the oral cavity.
    Chien CY; Su CY; Chuang HC; Fang FM; Huang HY; Chen CM; Chen CH; Huang CC
    J Surg Oncol; 2008 Mar; 97(3):273-7. PubMed ID: 18161864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.